1. Home
  2. COKE vs ABVX Comparison

COKE vs ABVX Comparison

Compare COKE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coca-Cola Consolidated Inc.

COKE

Coca-Cola Consolidated Inc.

HOLD

Current Price

$165.94

Market Cap

10.0B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$123.43

Market Cap

9.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
COKE
ABVX
Founded
1902
2013
Country
United States
France
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
9.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
COKE
ABVX
Price
$165.94
$123.43
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$112.83
AVG Volume (30 Days)
463.7K
1.7M
Earning Date
10-29-2025
08-11-2025
Dividend Yield
0.60%
N/A
EPS Growth
22.14
N/A
EPS
7.03
N/A
Revenue
$7,070,308,000.00
$7,073,400.00
Revenue This Year
N/A
$6.80
Revenue Next Year
N/A
N/A
P/E Ratio
$23.59
N/A
Revenue Growth
4.22
N/A
52 Week Low
$105.21
$4.77
52 Week High
$168.21
$138.49

Technical Indicators

Market Signals
Indicator
COKE
ABVX
Relative Strength Index (RSI) 67.36 59.90
Support Level $159.13 $107.06
Resistance Level $168.21 $138.49
Average True Range (ATR) 3.73 7.15
MACD -1.32 0.19
Stochastic Oscillator 70.70 58.28

Price Performance

Historical Comparison
COKE
ABVX

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: